GSK research aims to unlock P-med sales
GlaxoSmithKline (GSK) has unveiled new research to help pharmacists “unlock behind-the-counter sales".
GSK said the research has revealed opportunities to accelerate the growth of the pharmacy-only section of the market through “optimising the back wall”.
Paul Griffith, senior manager, global shopper insights at GSK, said prescriptions are a “driving factor” for shoppers to visit the pharmacy, which highlights a “key opportunity” to secure unplanned purchases.
“We suggest clear signage and in-store communications to encourage shoppers to speak to the pharmacist about their needs,” Mr Griffith said.
He also recommended merchandising the back wall in a way that mirrors the healthcare aisle. "For example, showing clear sub-categories and featuring seasonal products," Mr Griffith added.
The 'back wall project' is part of GSK’s ‘Pharmacy of the Future’ initiative.
For more information, contact your local GSK sales representative.
Will you order this product?